Highlights
ASX: CYP       CYNATA THERAPEUTICS LIMITED
Last Price Today's Change   Day's Range   Trading Volume
1.74   +0.14 (8.75%)  1.74 - 1.85  963,831

Overview

 
Avg Volume (4 weeks):121,313
4 Weeks Range:1.175 - 1.85
4 Weeks Price Volatility (%):
83.70%
52 Weeks Range:0.94 - 1.85
52 Weeks Price Volatility (%):
87.91%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Cynata Therapeutics Limited is a stem cell and regenerative medicine company. The Company is engaged in the development and commercialization of a mesenchymal stem cell (MSC) technology for human therapeutic use, Cymerus. Its Cymerus technology facilitates manufacture of MSCs from a single donor and a single donation. The Company's Cymerus platform stem cell technology is based upon stem cells known as mesenchymoangioblasts (MCAs). The Company's technology utilizes induced pluripotent stem cells (iPSCs) originating from an adult donor as the starting material for generating MCAs and in turn for manufacturing the MSC therapeutic product. The Cymerus platform provides a source of MSCs that is independent of donor limitations and provides an off-the-shelf stem cell platform for therapeutic product use. The Company's MSCs produced using Cymerus technology, can be used to treat unrelated patients, without any need to match the recipient to the donor.

  Be the first to like this.
 


 

742  456  689  9268 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 MEB 0.02+0.008 
 BLK 0.013+0.001 
 PCL 0.002+0.001 
 EXO 0.0020.00 
 SPX 0.032+0.003 
 PMY 0.009+0.001 
 IBX 0.05-0.001 
 S32 3.01+0.03 
 AB1 0.1650.00 
 NOROA 0.0010.00 
Partners & Brokers